SAROJA — Saroja Pharma Industries India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹152.78m
- IN₹210.13m
- IN₹406.69m
- 32
- 80
- 42
- 52
Annual cashflow statement for Saroja Pharma Industries India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.15 | 10.4 | 15.8 | 14.9 | 12.1 |
| Depreciation | |||||
| Non-Cash Items | 1.58 | 3.25 | 7.91 | 13.1 | 12.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.6 | -24.3 | -60.9 | -6.71 | -15.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.86 | -10.5 | -36.7 | 21.9 | 10.2 |
| Capital Expenditures | -0.227 | -0.544 | -3.08 | -47.3 | -47.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.011 | 0.04 | -0.269 | -0.898 | -0.331 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.238 | -0.504 | -3.35 | -48.2 | -47.6 |
| Financing Cash Flow Items | — | -3.29 | -8.01 | -13.2 | 61.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.72 | 10.3 | 42.7 | 27.3 | 37 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.614 | -0.712 | 2.6 | 0.995 | -0.423 |